$1.5 Billion is the total value of HealthCor Management, L.P.'s 64 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 41.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | BIOGEN INC | $84,590,000 | -22.2% | 401,660 | -11.4% | 5.64% | -4.7% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $81,956,000 | +52.7% | 1,850,450 | +46.4% | 5.47% | +87.2% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $74,711,000 | -16.7% | 710,110 | -14.7% | 4.98% | +2.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $59,291,000 | +321.2% | 769,016 | +382.7% | 3.96% | +416.3% |
| NTRA | Buy | NATERA INC | $58,967,000 | -16.1% | 1,449,536 | +92.5% | 3.93% | +2.8% |
| ABT | Buy | ABBOTT LABS | $57,374,000 | +101.1% | 484,740 | +139.1% | 3.83% | +146.6% |
| XBI | New | SPDR SER TRcall | $53,928,000 | – | 600,000 | +100.0% | 3.60% | – |
| CNC | Sell | CENTENE CORP DEL | $53,428,000 | -13.6% | 634,610 | -15.4% | 3.56% | +5.9% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $51,195,000 | -26.0% | 330,910 | -36.5% | 3.42% | -9.3% |
| HUM | Buy | HUMANA INC | $47,451,000 | +87.2% | 109,040 | +99.6% | 3.16% | +129.5% |
| COO | Buy | COOPER COS INC | $45,346,000 | +35.1% | 108,590 | +35.5% | 3.02% | +65.6% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $44,545,000 | -39.8% | 914,490 | -44.3% | 2.97% | -26.2% |
| CYTK | Buy | CYTOKINETICS INC | $41,783,000 | +874.0% | 1,135,110 | +1106.0% | 2.79% | +1096.1% |
| ABBV | Buy | ABBVIE INC | $41,202,000 | +143.2% | 254,160 | +103.1% | 2.75% | +198.0% |
| LIVN | Buy | LIVANOVA PLC | $41,107,000 | +9.2% | 502,350 | +16.7% | 2.74% | +33.8% |
| INCY | Buy | INCYTE CORP | $39,742,000 | +401.1% | 500,400 | +363.1% | 2.65% | +513.7% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $38,718,000 | -65.6% | 530,160 | -70.6% | 2.58% | -57.8% |
| BDX | New | BECTON DICKINSON & CO | $37,628,000 | – | 141,460 | +100.0% | 2.51% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $37,014,000 | +154.2% | 72,580 | +150.3% | 2.47% | +211.7% |
| ANTM | Sell | ANTHEM INC | $36,031,000 | -23.5% | 73,350 | -27.8% | 2.40% | -6.2% |
| TFX | New | TELEFLEX INCORPORATED | $35,181,000 | – | 99,150 | +100.0% | 2.35% | – |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $33,108,000 | -10.6% | 228,410 | -20.0% | 2.21% | +9.6% |
| MCK | Buy | MCKESSON CORP | $29,327,000 | +84.1% | 95,800 | +49.5% | 1.96% | +125.6% |
| CVS | New | CVS HEALTH CORP | $29,007,000 | – | 286,600 | +100.0% | 1.94% | – |
| DHR | Sell | DANAHER CORPORATION | $28,597,000 | -42.3% | 97,490 | -35.3% | 1.91% | -29.2% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $27,757,000 | +17.3% | 1,423,425 | -1.8% | 1.85% | +43.8% |
| AMGN | Buy | AMGEN INC | $26,332,000 | +87.3% | 108,890 | +74.3% | 1.76% | +129.7% |
| THC | Sell | TENET HEALTHCARE CORP | $24,389,000 | -61.8% | 283,730 | -63.7% | 1.63% | -53.2% |
| CCXI | Buy | CHEMOCENTRYX INC | $23,985,000 | +173.9% | 956,740 | +297.8% | 1.60% | +235.4% |
| WOOF | Sell | PETCO HEALTH & WELLNESS CO I | $23,778,000 | -56.0% | 1,215,000 | -55.5% | 1.59% | -46.0% |
| HSIC | Buy | HENRY SCHEIN INC | $22,254,000 | +124.9% | 255,230 | +100.0% | 1.48% | +176.0% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $20,517,000 | -19.0% | 1,180,500 | +2.0% | 1.37% | -0.7% |
| CAH | New | CARDINAL HEALTH INC | $17,990,000 | – | 317,280 | +100.0% | 1.20% | – |
| RACB | RESEARCH ALLIANCE CORP II | $12,930,000 | +0.4% | 1,324,800 | 0.0% | 0.86% | +23.1% | |
| PFE | Sell | PFIZER INC | $12,574,000 | -37.2% | 242,880 | -28.4% | 0.84% | -23.0% |
| HCA | Sell | HCA HEALTHCARE INC | $12,253,000 | -43.4% | 48,890 | -42.0% | 0.82% | -30.6% |
| SYK | Sell | STRYKER CORPORATION | $11,699,000 | -72.5% | 43,760 | -72.5% | 0.78% | -66.3% |
| AFMD | AFFIMED N V | $7,525,000 | -20.8% | 1,721,925 | 0.0% | 0.50% | -2.9% | |
| QTRX | Buy | QUANTERIX CORP | $7,197,000 | +26.4% | 246,540 | +83.5% | 0.48% | +54.8% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $7,054,000 | – | 200,000 | +100.0% | 0.47% | – |
| REGN | Sell | REGENERON PHARMACEUTICALS | $6,684,000 | -62.6% | 9,570 | -66.2% | 0.45% | -54.2% |
| IMGN | IMMUNOGEN INC | $6,237,000 | -35.9% | 1,310,340 | 0.0% | 0.42% | -21.4% | |
| Buy | HYPERFINE INC | $6,195,000 | +23.6% | 1,750,000 | +153.0% | 0.41% | +51.3% | |
| RAPT | Buy | RAPT THERAPEUTICS INC | $5,809,000 | -12.8% | 264,150 | +45.6% | 0.39% | +6.9% |
| CANO | Sell | CANO HEALTH INC | $4,521,000 | -68.0% | 711,970 | -55.1% | 0.30% | -60.7% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,715,000 | -88.7% | 228,450 | -90.4% | 0.25% | -86.2% |
| ALKS | New | ALKERMES PLC | $3,700,000 | – | 140,630 | +100.0% | 0.25% | – |
| IBB | New | ISHARES TRishares biotech | $3,677,000 | – | 28,220 | +100.0% | 0.24% | – |
| STXS | Buy | STEREOTAXIS INC | $3,066,000 | -24.7% | 821,850 | +25.2% | 0.20% | -7.7% |
| MRUS | MERUS N V | $2,955,000 | -16.9% | 111,760 | 0.0% | 0.20% | +2.1% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,201,000 | -92.9% | 23,480 | -93.6% | 0.15% | -91.3% |
| LPTX | LEAP THERAPEUTICS INC | $1,867,000 | -46.0% | 1,066,689 | 0.0% | 0.12% | -33.5% | |
| IKNA | IKENA ONCOLOGY INC | $1,754,000 | -51.4% | 287,621 | 0.0% | 0.12% | -40.3% | |
| GLPG | New | GALAPAGOS NVspon adr | $1,472,000 | – | 23,740 | +100.0% | 0.10% | – |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $1,427,000 | -96.8% | 9,170 | -97.4% | 0.10% | -96.1% |
| GERN | New | GERON CORP | $1,224,000 | – | 900,000 | +100.0% | 0.08% | – |
| PCRX | New | PACIRA BIOSCIENCES INC | $1,063,000 | – | 13,930 | +100.0% | 0.07% | – |
| Sell | PYXIS ONCOLOGY INC | $879,000 | -67.3% | 217,457 | -11.2% | 0.06% | -59.6% | |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $830,000 | – | 13,570 | +100.0% | 0.06% | – |
| LGVWS | LONGVIEW ACQUISITION CORP II*w exp 99/99/999 | $179,000 | -50.7% | 427,178 | 0.0% | 0.01% | -40.0% | |
| EQRX INC*w exp 12/17/202 | $81,000 | -24.3% | 99,998 | 0.0% | 0.01% | -16.7% | ||
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $43,000 | -51.7% | 137,305 | 0.0% | 0.00% | -40.0% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $35,000 | -41.7% | 82,663 | 0.0% | 0.00% | -33.3% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $15,000 | -66.7% | 78,059 | 0.0% | 0.00% | -50.0% | |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -10,000 | -100.0% | -0.01% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -74,774 | -100.0% | -0.10% | – | |
| OHPA | Exit | ORION ACQUISITION CORP | $0 | – | -199,751 | -100.0% | -0.11% | – |
| AXNX | Exit | AXONICS INC | $0 | – | -58,920 | -100.0% | -0.18% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -17,490 | -100.0% | -0.22% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -104,482 | -100.0% | -0.23% | – |
| Exit | ARYA SCIENCES ACQUISITN CORP | $0 | – | -500,000 | -100.0% | -0.26% | – | |
| VCYT | Exit | VERACYTE INC | $0 | – | -119,710 | -100.0% | -0.27% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -33,890 | -100.0% | -0.28% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -428,380 | -100.0% | -0.98% | – |
| LGV | Exit | LONGVIEW ACQUISITION CORP II | $0 | – | -2,135,900 | -100.0% | -1.14% | – |
| MDT | Exit | MEDTRONIC PLCcall | $0 | – | -275,000 | -100.0% | -1.55% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -409,230 | -100.0% | -1.80% | – |
| XLV | Exit | SELECT SECTOR SPDR TRsbi healthcare | $0 | – | -254,230 | -100.0% | -1.95% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -279,810 | -100.0% | -2.60% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -1,530,580 | -100.0% | -8.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.